risperidone has been researched along with Addiction, Opioid in 3 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These withdrawal symptoms resolved soon after risperidone was discontinued." | 1.30 | Opioid withdrawal during risperidone treatment. ( Weiss, RD; Wines, JD, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCarthy, M | 1 |
| Drozdov, ES | 1 |
| Wines, JD | 1 |
| Weiss, RD | 1 |
1 trial available for risperidone and Addiction, Opioid
| Article | Year |
|---|---|
[Rispolept (risperidone) efficacy in the treatment of patients with schizophrenia and psychoactive drug dependence].
Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Male; Opioid-Related Disorders; Psychotropi | 2002 |
2 other studies available for risperidone and Addiction, Opioid
| Article | Year |
|---|---|
Companies to pay $39.5m in OxyContin and Risperdal cases.
Topics: Analgesics, Opioid; Compensation and Redress; Consumer Product Safety; Dopamine Antagonists; Drug In | 2015 |
Opioid withdrawal during risperidone treatment.
Topics: Adult; Antipsychotic Agents; Female; Humans; Male; Opioid-Related Disorders; Risperidone; Substance | 1999 |